Detalles de la búsqueda
1.
Helicobacter pylori eradication for primary prevention of peptic ulcer bleeding in older patients prescribed aspirin in primary care (HEAT): a randomised, double-blind, placebo-controlled trial.
Lancet
; 400(10363): 1597-1606, 2022 11 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36335970
2.
Recruitment to a large scale randomised controlled clinical trial in primary care: the Helicobacter Eradication Aspirin Trial (HEAT).
Trials
; 23(1): 140, 2022 Feb 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35164864
3.
Aspirin to target arterial events in chronic kidney disease (ATTACK): study protocol for a multicentre, prospective, randomised, open-label, blinded endpoint, parallel group trial of low-dose aspirin vs. standard care for the primary prevention of cardiovascular disease in people with chronic kidney disease.
Trials
; 23(1): 331, 2022 Apr 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-35449015
4.
The Helicobacter Eradication Aspirin Trial (HEAT): A Large Simple Randomised Controlled Trial Using Novel Methodology in Primary Care.
EBioMedicine
; 2(9): 1200-4, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26501118
5.
Dose-intense cyclophosphamide and etoposide for patients with refractory or high-risk non-Hodgkin's lymphoma.
Clin Lymphoma
; 5(2): 116-22, 2004 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-15453927
6.
Pharmacology and gastrointestinal safety of lumiracoxib, a novel cyclooxygenase-2 selective inhibitor: An integrated study.
Clin Gastroenterol Hepatol
; 2(2): 113-20, 2004 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-15017615
7.
High-dose cyclophosphamide and etoposide for patients with refractory acute myeloid leukemia: a case series.
Am J Hematol
; 73(4): 295-6, 2003 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-12879438
Resultados
1 -
7
de 7
1
Próxima >
>>